In contrast, mRNA levels of host, but not cancer cell-derived VEGF-A, were significantly up-regulated following Ad(s)VEGFR2 treatment (p < 0.001), while Ad(sh)PlGF treatment did not affect VEGF-A levels (Figure 3B). Here, VEGFA is linked to cancer.